Preparation and characterization of pH-responsive ionic crosslinked microparticles of mercaptopurine to target ulcerative colitis

Abstract

The objective of this study was the preparation of ionically crosslinked 6-mercaptopurine (6-MP) monohydrate microparticles through preparing polyelectrolyte complexes of drug and polymers. Polymers such as chitosan, casein, and carrageenan were used to prepare crosslinked microparticles, and sodium tripolyphosphate was used as crosslinker. Microparticles were characterized for their flow behavior, compressibility, percentage yield, micromeritic, and entrapment efficiency. Scanning electron microscopy was conducted to understand the surface morphology of the microparticles, and the result was correlated with the swelling index and percentage drug release. Mathematical modeling of drug release in order to determine the drug release kinetics was also determined to understand the mechanism involving the release of 6-mercaptopurine from the microparticles. The ionic crosslinked microparticles were in the range of 664 μm–798 μm particle size having good flow and compressibility properties with percentage yield were found to be from 77.5% to 87.5% in range. The entrapment efficiency for the formulations were found to be from 63.5% to 83.5%, with MCP-5 gave maximum entrapment efficiency of 83.5%. In vitro swelling and drug release studies were in accordance with the polymer properties following zero-order model with super-case transport II.

Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation

“…The short half-life problem, as well as side symptoms such as diarrhea, muscle cramps, vertigo, sleeplessness, rhinitis, dry cough, elevated blood potassium, and libido has necessitated the development of an alternate dosage form; whether reduce the frequency of dose or improve the drug's efficacy ( Mokale et al, 2014 ). Strategies such as prolonged release formulations of lowering the drug's hepatic metabolism might be useful in increasing the efficiency of a medicine using smaller amounts ( Kommana et al, 2020 , Hameed et al, 2021 ).…”

Prunus armeniaca Gum-Alginate Polymeric Microspheres to Enhance the Bioavailability of Tramadol Hydrochloride: Formulation and Evaluation

“…Microencapsulation technology, along with prolonged drug availability, provides drug protection from hostile conditions and incompatibilities with reduced toxicity, improved efficacy, and better patient compliance [ 6 , 7 , 8 ]. Among these carrier devices, alginate-based microspheres are one of the prevalently studied carrier devices offering both controlled and targeted delivery [ 9 , 10 , 11 ]. The hydrophilic functional groups enable alginate to fabricate a porous three-dimensional architecture with phenomenal water-absorbing properties leading to controlled, modified, delayed, and extended-release formulations.…”